Over-expression of neuron-derived orphan receptor-1 (NOR-1) exacerbates neointimal hyperplasia after vascular injury

Human Molecular Genetics

Volumn 22, Issue 10, 2013, Pages 1949-1959

  Rodríguez calvo, Ricardo ^a   Guadall, Anna ^a   Calvayrac, Olivier ^a   Navarro, María A ^b   Alonso, Judith ^a   Ferrán, Beatriz ^a   De diego, Alicia ^c   Muniesa, Pedro ^b   Osada, Jesús ^b   Rodríguez, Cristina ^a   Martínez gonzález, José ^a  

^a Institut Català de Ciències Cardiovasculars   (Spain)

^b UNIVERSITY OF ZARAGOZA   (Spain)

^c INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MYOSIN HEAVY CHAIN; NUCLEAR RECEPTOR NR4A3; THYMIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; BACKCROSSING; BLOOD VESSEL INJURY; C57BL 6 MOUSE; CAROTID ARTERY; CAROTID ARTERY LIGATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE EXACERBATION; ENZYME ACTIVITY; GEL MOBILITY SHIFT ASSAY; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MITOGENESIS; MOUSE; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; CAROTID ARTERIES; CAROTID ARTERY INJURIES; DNA-BINDING PROTEINS; HUMANS; HYPERPLASIA; MICE; MICE, TRANSGENIC; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NEOINTIMA; NERVE TISSUE PROTEINS; RATS; RECEPTORS, STEROID; RECEPTORS, THYROID HORMONE;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 84877014275     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt042     Document Type: Article

References (42)

1. Dzau, V.J., Braun-Dullaeus, R.C. and Sedding, D.G. (2002) Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat. Med., 8, 1249-1256.
2. Fuster, J.J., Fernandez, P., Gonzalez-Navarro, H., Silvestre, C., Abu Nabah, Y.N. and Andres, V. (2010) Control of cell proliferation in atherosclerosis: insights from animal models and human studies. Cardiovasc. Res., 86, 254-264.
3. Daemen, J. and Serruys, P.W. (2007) Drug-eluting stent update 2007: part I. A survey of current and future generation drug-eluting stents: meaningful advances or more of the same? Circulation, 116, 316-328.
4. Wessely, R. (2010) New drug-eluting stent concepts. Nat. Rev. Cardiol., 7, 194-203.
5. Andres, V. (2004) Control of vascular cell proliferation and migration by cyclin-dependent kinase signalling: new perspectives and therapeutic potential. Cardiovasc. Res., 63, 11-21.
6. Kumar, M.S. and Owens, G.K. (2003) Combinatorial control of smooth muscle-specific gene expression. Arterioscler. Thromb. Vasc. Biol., 23, 737-747.
7. Martinez-Gonzalez, J., Rius, J., Castello, A., Cases-Langhoff, C. and Badimon, L. (2003) Neuron-derived orphan receptor-1 (NOR-1) modulates vascular smooth muscle cell proliferation. Circ. Res., 92, 96-103.
8. Nomiyama, T., Nakamachi, T., Gizard, F., Heywood, E.B., Jones, K.L., Ohkura, N., Kawamori, R., Conneely, O.M. and Bruemmer, D. (2006) The NR4A orphan nuclear receptor NOR1 is induced by platelet-derived growth factor and mediates vascular smooth muscle cell proliferation. J. Biol. Chem., 281, 33467-33476.
9. Martinez-Gonzalez, J. and Badimon, L. (2005) The NR4A subfamily of nuclear receptors: new early genes regulated by growth factors in vascular cells. Cardiovasc. Res., 65, 609-618.
10. Bonta, P.I., Pols, T.W. and de Vries, C.J. (2007) NR4A nuclear receptors in atherosclerosis and vein-graft disease. Trends Cardiovasc. Med., 17, 105-111.
11. Zhao, Y. and Bruemmer, D. (2009) NR4A Orphan Nuclear Receptors in Cardiovascular Biology. Drug Discov. Today Dis. Mech., 6, e43-e48.
12. Wang, Z., Benoit, G., Liu, J., Prasad, S., Aarnisalo, P., Liu, X., Xu, H., Walker, N.P. and Perlmann, T. (2003) Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors. Nature, 423, 555-560.
13. Arkenbout, K., de Waard, V., van Bragt, M., van Achterberg, T., Grimberg, J., Pichon, B., Pannekoek, H. and de Vries, C.J. (2002) Protective function of transcription factor TR3 orphan receptor in atherogenesis: decreased lesion formation in carotid artery ligation model in TR3 transgenic mice. Circulation, 106, 1530-1535.
14. Arkenbout, E.K., van Bragt, M., Eldering, E., van Bree, C., Grimbergen, J.M., Quax, P.H., Pannekoek, H. and de Vries, C.J. (2003) TR3 orphan receptor is expressed in vascular endothelial cells and mediates cell cycle arrest. Arterioscler. Thromb. Vasc. Biol., 23, 1535-1540.
15. Bonta, P.I., van Tiel, C.M., Vos, M., Pols, T.W., van Thienen, J.V., Ferreira, V., Arkenbout, E.K., Seppen, J., Spek, C.A., van der Poll, T. et al. (2006) Nuclear receptors Nur77, Nurr1, and NOR-1 expressed in atherosclerotic lesion macrophages reduce lipid loading and inflammatory responses. Arterioscler. Thromb. Vasc. Biol, 26, 2288-2294.
16. Zhao, Y., Howatt, D.A., Gizard, F., Nomiyama, T., Findeisen, H.M., Heywood, E.B., Jones, K.L., Conneely, O.M., Daugherty, A. and Bruemmer, D. (2010) Deficiency of the NR4A orphan nuclear receptor NOR1 decreases monocyte adhesion and atherosclerosis. Circ. Res., 107, 501-511.
17. Nomiyama, T., Zhao, Y., Gizard, F., Findeisen, H.M., Heywood, E.B., Jones, K.L., Conneely, O.M. and Bruemmer, D. (2009) Deficiency of the NR4A neuron-derived orphan receptor-1 attenuates neointima formation after vascular injury. Circulation, 119, 577-586.
18. Rius, J., Martinez-Gonzalez, J., Crespo, J. and Badimon, L. (2004) Involvement of neuron-derived orphan receptor-1 (NOR-1) in LDL-induced mitogenic stimulus in vascular smooth muscle cells: role of CREB. Arterioscler. Thromb. Vasc. Biol., 24, 697-702.
19. Crespo, J., Martinez-Gonzalez, J., Rius, J. and Badimon, L. (2005) Simvastatin inhibits NOR-1 expression induced by hyperlipemia by interfering with CREB activation. Cardiovasc. Res., 67, 333-341.
20. Liu, D., Jia, H., Holmes, D.I., Stannard, A. and Zachary, I. (2003) Vascular endothelial growth factor-regulated gene expression in endothelial cells: KDR-mediated induction of Egr3 and the related nuclear receptors Nur77, Nurr1, and Nor1. Arterioscler. Thromb. Vasc. Biol., 23, 2002-2007.
21. Rius, J., Martinez-Gonzalez, J., Crespo, J. and Badimon, L. (2006) NOR-1 is involved in VEGF-induced endothelial cell growth. Atherosclerosis, 184, 276-282.
22. Martorell, L., Martínez-González, J., Crespo, J., Calvayrac, O. and Badimon, L. (2007) Neuron-derived orphan receptor-1 (NOR-1) is induced by thrombin and mediates vascular endothelial cell growth. J. Thromb. Haemost., 5, 1766-1773.
23. DeYoung, R.A., Baker, J.C., Cado, D. and Winoto, A. (2003) The orphan steroid receptor Nur77 family member Nor-1 is essential for early mouse embryogenesis. J. Biol. Chem., 278, 47104-47109.
24. Maira, M., Martens, C., Philips, A. and Drouin, J. (1999) Heterodimerization between members of the Nur subfamily of orphan nuclear receptors as a novel mechanism for gene activation. Mol. Cell. Biol., 19, 7549-7557.
25. Assinder, S.J., Stanton, J.A. and Prasad, P.D. (2009) Transgelin: an actin-binding protein and tumour suppressor. Int. J. Biochem. Cell Biol., 41, 482-486.
26. Li, L., Miano, J.M., Mercer, B. and Olson, E.N. (1996) Expression of the SM22alpha promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells. J. Cell Biol., 132, 849-859.
27. Solway, J., Seltzer, J., Samaha, F.F., Kim, S., Alger, L.E., Niu, Q., Morrisey, E.E., Ip, H.S. and Parmacek, M.S. (1995) Structure and expression of a smooth muscle cell-specific gene, SM22 alpha. J. Biol. Chem., 270, 13460-13469.
28. Kakkar, R., Ye, B., Stoller, D.A., Smelley, M., Shi, N.Q., Galles, K., Hadhazy, M., Makielski, J.C. and McNally, E.M. (2006) Spontaneous coronary vasospasm in KATP mutant mice arises from a smooth muscle-extrinsic process. Circ. Res., 98, 682-689.
29. Li, L., Miano, J.M., Cserjesi, P. and Olson, E.N. (1996) SM22 alpha, a marker of adult smooth muscle, is expressed in multiple myogenic lineages during embryogenesis. Circ. Res., 78, 188-195.
30. Rensen, S.S., Doevendans, P.A. and van Eys, G.J. (2007) Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. Neth. Heart J., 15, 100-108.
31. Kumar, A. and Lindner, V. (1997) Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscler. Thromb. Vasc. Biol., 17, 2238-2244.
32. Pires, N.M., Pols, T.W., de Vries, M.R., van Tiel, C.M., Bonta, P.I., Vos, M., Arkenbout, E.K., Pannekoek, H., Jukema, J.W., Quax, P.H. et al. (2007) Activation of nuclear receptor Nur77 by 6-mercaptopurine protects against neointima formation. Circulation, 115, 493-500.
33. Bonta, P.I., Pols, T.W., van Tiel, C.M., Vos, M., Arkenbout, E.K., Rohlena, J., Koch, K.T., de Maat, M.P., Tanck, M.W., de Winter, R.J. et al. (2010) Nuclear receptor Nurr1 is expressed in and is associated with human restenosis and inhibits vascular lesion formation in mice involving inhibition of smooth muscle cell proliferation and inflammation. Circulation, 121, 2023-2032.
34. Owens, G.K., Kumar, M.S. and Wamhoff, B.R. (2004) Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev., 84, 767-801.
35. Gizard, F., Zhao, Y., Findeisen, H.M., Qing, H., Cohn, D., Heywood, E.B., Jones, K.L., Nomiyama, T. and Bruemmer, D. (2011) Transcriptional regulation of S phase kinase-associated protein 2 by NR4A orphan nuclear receptor NOR1 in vascular smooth muscle cells. J. Biol. Chem., 286, 35485-35493.
36. Ohkura, N., Ito, M., Tsukada, T., Sasaki, K., Yamaguchi, K. and Miki, K. (1996) Structure, mapping and expression of a human NOR-1 gene, the third member of the Nur77/NGFI-B family. Biochim. Biophys. Acta, 1308, 205-214.
37. Nagy, A., Gertsenstein, M., Vintersten, K. and Behringer, R. (2003) Manipulating the Mouse Embryo: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
38. Churchman, A.T. and Siow, R.C. (2009) Isolation, culture and characterisation of vascular smooth muscle cells. Methods Mol. Biol., 467, 127-138.
39. Guadall, A., Orriols, M., Rodriguez-Calvo, R., Calvayrac, O., Crespo, J., Aledo, R., Martinez-Gonzalez, J. and Rodriguez, C. (2011) Fibulin-5 is up-regulated by hypoxia in endothelial cells through A HIF-1{alpha} dependent mechanism. J. Biol. Chem., 286, 7093-7103.
40. Fuster, J.J., González-Navarro, H., Vinué, A., Molina-Sànchez, P., Andrés-Manzano, M.J., Nakayama, K.I., Nakayama, K., Díez-Juan, A., Bernad, A., Rodríguez, C. et al. (2011) Deficient p27 phosphorylation at serine 10 increases macrophage foam cell formation and aggravates atherosclerosis through a proliferation-independent mechanism. Arterioscler. Thromb. Vasc. Biol., 31, 2455-2463.
41. Martorell, L., Gentile, M., Rius, J., Rodriguez, C., Crespo, J., Badimon, L. and Martinez-Gonzalez, J. (2009) The hypoxia-inducible factor 1/NOR-1 axis regulates the survival response of endothelial cells to hypoxia. Mol. Cell Biol., 29, 5828-5842.
42. Zhang, L.N., Wilson, D.W., da Cunha, V., Sullivan, M.E., Vergona, R., Rutledge, J.C. and Wang, Y.X. (2006) Endothelial NO synthase deficiency promotes smooth muscle progenitor cells in association with upregulation of stromal cell-derived factor-1alpha in a mouse model of carotid artery ligation. Arterioscler. Thromb. Vasc. Biol., 26, 765-772.